1. Arteaga CL, Adamson PC, Engelman JA, Foti M, Gaynor RB,
Hilsenbeck SG, et al. AACR Cancer Progress Report 2014. Clin
Cancer Res 2014;20:S1–112.
2. American Cancer Society. Cancer Facts & Figures 2017. Atlanta
(GA): American Cancer Society; 2017.
3. Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson AB, et
al. Annual report to the nation on the status of cancer, 1975–2014,
featuring survival. J Natl Cancer Inst 2017; 109.
4. CurtinSC,MiniñoAM, AndersonRN.Declinesincancerdeathrates
among children and adolescents in the United States, 1999–2014.
NCHS Data Brief 2016;257: 1–8.
5. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary
CL, et al. SEER Cancer Statistics Review, 1975-2014, National Cancer
Institute. Bethesda, MD. https://seer.cancer.gov/csr/1975_2014/,
based on November 2016 SEER data submission, posted to the
SEER website, April 2017 [cited 2017 Jul 31].
6. Christopher P, Murray JL. Global, regional, and national life
expectancy, all-cause mortality, and cause-specific mortality for
249 causes of death, 1980–2015: a systematic analysis for the Global
Burden of Disease Study 2015. Lancet 2016;388:1459-1544.
7. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C,
Rebelo M, et al. GLOBOCAN 2012 v1.0, Cancer incidence and
mortality worldwide: IARC CancerBase No. 11. Lyon, France:
International Agency for Research on Cancer; 2013 [cited 2017
Jul 31]. Available from: http://globocan.iarc.fr.
8. National Cancer Institute. Cancer Health Disparities Definitions
[cited 2017 Jul 31]. Available from: https://www.cancer.gov/about-nci/organization/crchd/about-health-disparities/definitions.
9. American Cancer Society. Cancer Facts & Figures for Hispanics/
Latinos 2015-2017. Atlanta (GA): American Cancer Society; 2015.
10. MokdadAH,Dwyer-LindgrenL,FitzmauriceC,StubbsRW,Bertozzi-Villa A, Morozoff C, et al. Trends and patterns of disparities in cancer
mortality among US counties, 1980-2014. JAMA 2017;317:388–406.
11. Hodeib M, Chang J, Liu F, Ziogas A, Dilley S, Randall LM, et al.
Socioeconomic status as a predictor of adherence to treatment
guidelines for early-stage ovarian cancer. Gynecol Oncol
12. Walker GV, Grant SR, Guadagnolo BA, Hoffman KE, Smith BD,
Koshy M, et al. Disparities in stage at diagnosis, treatment, and
survival in nonelderly adult patients with cancer according to
insurance status. J Clin Oncol 2014;32:3118–25.
13. Cochran SD, Mays VM. Risk of breast cancer mortality among
women cohabiting with same sex partners: findings from the
National Health Interview Survey, 1997-2003. J Womens Health
14. Wolfson J, Sun CL, Wyatt L, Stock W, Bhatia S. Adolescents and
young adults with acute lymphoblastic leukemia and acute myeloid
leukemia: impact of care at specialized cancer centers on survival
outcome. Cancer Epidemiol Biomarkers Prev 2017;26:312–20.
15. Deroche CB, McDermott SW, Mann JR, Hardin JW. Colorectal
cancer screening adherence in selected disabilities over 10 years.
Am J Prev Med 2017;52:735–41.
16. National Cancer Institute. Surveillance, epidemiology, and end
results (SEER) program cancer stat facts: cancer of any site [cited
2017 Jul 31]. Available from: https://seer.cancer.gov/statfacts/html/
17. Colby SL, Ortman JM. Projections of the size and composition of
the U.S. population: 2014 to 2060. Current Population Reports,
P25-1143. U. S. Census Bureau, Washington (DC); 2014.
18. U. S. Census Bureau, Population Division. Annual estimates of the
resident population by single year of age and sex for the United
States: April 1, 2010 to July 1, 2016. Washington (DC); 2017.
19. Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM.
Current cigarette smoking among adults — United States, 2005–
2015. MM WR Morb Mortal Wkly Rep 2016;65:1205–11.
20. Colditz GA, Wolin K Y, Gehlert S. Applying what we know to
accelerate cancer prevention. Sci Transl Med 2012;4:127rv4.
Fathima S, et al. The global economic burden of non-communicable
diseases. Geneva (Switzerland): World Economic Forum; 2011.
22. Collins FS, Anderson JM, Austin CP, Battey JF, Birnbaum LS, Briggs
JP, et al. Basic science: bedrock of progress. Science 2016;351:1405.
23. Tomasetti C, Vogelstein B. Cancer etiology. Variation in cancer
risk among tissues can be explained by the number of stem cell
divisions. Science 2015;347: 78–81.
24. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J,
Koskenvuo M, et al. Environmental and heritable factors in the
causation of cancer–analyses of cohorts of twins from Sweden,
Denmark, and England. N Engl J Med 2000;343: 78–85.
25. Baselga J, Bhardwaj N, Cantley LC, De Matteo R, DuBois RN, Foti
M, et al. AACR Cancer Progress Report 2015. Clin Cancer Res
26. Dawson MA. The cancer epigenome: Concepts, challenges, and
therapeutic opportunities. Science 2017;355:1147–52.
27. Mcgranahan N, Swanton C. Clonal heterogeneity and tumor
evolution: past, present, and the future. Cell 2017;168:613–28.
28. Hawkins ED, Duarte D, Akinduro O, Khorshed RA, Passaro D,
Nowicka M, et al. T-cell acute leukaemia exhibits dynamic interactions
with bone marrow microenvironments. Nature 2016;538:518–22.
29. Sun Y. Tumor microenvironment and cancer therapy resistance.
Cancer Lett 2016;380:205–15.
30. Davidson NE, Armstrong SA, Coussens LM, Cruz-Correa MR,
DeBerardinis RJ, Doroshow JH, et al. AACR Cancer Progress
Report 2016. Clin Cancer Res 2016;22:S1–137.
31. Emmons KM, Colditz GA. Realizing the potential of cancer
prevention - the role of implementation science. N Engl J Med
32. White MC, Holman DM, Massetti GM. Foreword: cancer prevention
can start early and last a lifetime. Pediatrics 2016;138:S1-2.